TrimRx vs Hims: Cost and Pricing Compared

Introduction

Hims is the most heavily marketed weight loss telehealth brand in 2026. Its promotional pricing catches attention with first-month rates often well below standard, but the post-promotion cost is what matters over a year of treatment.

TrimRx runs a more transparent flat-rate model: $199 entry for compounded semaglutide, $299 for compounded tirzepatide. No first-month promotions that revert later.

This breakdown compares published rates, annual totals, hidden fees, and total cost of ownership for typical patient profiles, so you can see what each program actually costs over the long run.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Does Hims Charge for Weight Loss Medication?

Hims compounded semaglutide ranges from $199 to $249 per month at standard pricing in 2025-2026. Promotional first-month pricing can drop below $99, with standard rates resuming month two.

Quick Answer: Hims compounded semaglutide ranges $199-$249 per month at standard pricing

The pricing covers compounded medication, clinician oversight, the Hims app, and shipping. Higher doses (1.0 mg, 1.7 mg, 2.4 mg) sometimes carry small upcharges, though Hims has generally kept pricing flatter than some competitors.

Hims doesn’t routinely offer tirzepatide. Patients who want tirzepatide need a different provider; TrimRx is one of the more accessible options.

What Does TrimRx Charge?

TrimRx semaglutide starts at $199 per month at entry doses. Tirzepatide starts at $299. The price covers compounded medication, clinician access, dose titration support, and shipping.

There’s no first-month promotional rate that reverts later. The pricing shown at intake is the standard ongoing rate. Quarterly and annual prepay options reduce the effective monthly rate by 10-20%.

The free assessment quiz returns the live quote based on your medication choice and any active promotions.

How Do Annual Costs Compare?

For semaglutide patients on standard pricing throughout the year: $2,388-$2,988 annually at either provider. Hims’ promotional first-month savings ($100-$150 typical) make year-one slightly cheaper, but year-two costs converge.

For tirzepatide patients: TrimRx at $329 average monthly (with titration adjustments) is $3,948 annually. Hims doesn’t offer this as a standard option, so the comparison ends.

Adding cardiometabolic benefits valuation changes the math. SELECT (Lincoff et al. 2023 NEJM) showed 20% MACE reduction on semaglutide. FLOW (Perkovic et al. 2024 NEJM) showed 24% kidney/CV death reduction. SURMOUNT-OSA earned FDA approval for tirzepatide in obstructive sleep apnea in December 2024. These benefits aren’t priced into either provider’s monthly fee.

What’s Included at Each Price?

Hims includes compounded medication, clinician messaging, shipping, the Hims app with educational content, and integration with the broader Hims account if you use other Hims products.

TrimRx includes compounded medication, clinician messaging, dose titration support, and shipping. No proprietary app, no broader product ecosystem.

The app is the main differentiator on bundled features. If you’ll use it actively, the value is real. If you won’t, both providers deliver similar core service.

Do Either Offer Significant Discounts?

Both run promotional pricing. Hims is heavier on first-month promos that drop below $99. TrimRx is heavier on quarterly and annual prepay discounts (10-20% off month-to-month).

Promotional rates always revert. Read the fine print to confirm post-promo standard pricing. Hims’ marketing emphasizes the entry rate; the standard rate is what determines annual cost.

For long-term value, the prepay discounts at TrimRx and similar providers typically offer larger total savings than first-month-only promos.

How Do Hidden Fees Stack Up?

Both providers don’t allow returns on shipped compounded medication. Cancellation needs to happen before the next bill date to avoid being charged for unused product.

Shipping is included in the standard monthly fee at both providers. Expedited reshipments after a missed delivery can incur fees at either company.

Lab work isn’t required by either provider for prescription approval in most cases. Patients with chronic conditions may be asked for recent labs. Direct-to-consumer panels run $80-$200.

Does Insurance Cover Either Provider?

No. Both are cash-pay only for compounded medication. Commercial insurance generally doesn’t cover compounded semaglutide or tirzepatide, since these aren’t FDA-approved drug applications.

HSA and FSA reimbursement is sometimes possible when medication is prescribed for diagnosed obesity (BMI 30+) or type 2 diabetes. Submit the receipt and prescription to your HSA/FSA administrator.

If you have commercial insurance that covers brand-name Wegovy® or Zepbound®, your insurance pharmacy benefit usually offers lower out-of-pocket cost than any compounded provider. Check coverage before signing up for cash-pay.

Key Takeaway: Hims promotional first-month pricing can drop below $99, reverting to standard rates after

How Does Cost-per-pound-lost Compare?

STEP 1 (Wilding et al. 2021 NEJM) showed semaglutide produced 14.9% mean weight loss at 68 weeks. For a 220-pound patient losing 33 pounds at $3,000 annual cost, that’s $91 per pound.

The math is similar at Hims and TrimRx for semaglutide patients, since pricing converges. Tirzepatide cost-per-pound is also around $91 per pound when comparing $4,200 annual cost against 46-pound average loss from SURMOUNT-1’s 20.9% benchmark.

Cost-per-pound is mostly driven by adherence and titration to therapeutic dose, not provider choice. Patients who stop before week 16-20 pay much more per pound because the weight loss curve accelerates after that point.

What About Year Two and Beyond?

STEP 4 showed weight regain after stopping semaglutide. Maintenance dosing is needed to sustain results long-term.

Maintenance dose costs are similar to active titration costs at both providers, though some patients drop to lower doses that may cost less. Annual maintenance budget: $2,400-$3,000 for semaglutide, $3,000-$4,000 for tirzepatide.

Hims’ large marketing budget suggests promotional pricing will continue. TrimRx’s flat-rate model is more predictable. Long-term cost projections favor the more predictable provider for budgeting purposes.

Which Is the Better Cost Value?

For semaglutide-only patients on first year: Hims has a slight edge from promotional pricing. After year one, costs converge.

For tirzepatide patients: TrimRx, because Hims doesn’t routinely offer it.

For patients who value flat predictable pricing: TrimRx. For patients who value the broader Hims ecosystem and don’t mind navigating promo-to-standard transitions: Hims.

Run the TrimRx free assessment quiz for a personalized quote, and compare to Hims’ intake quote. Both intakes are free.

How Does Long-term Cost Scale with Maintenance Dosing?

STEP 4 (Rubino et al. 2021 JAMA) followed patients after week 20 of semaglutide titration. Patients who continued at 2.4 mg maintained weight loss; patients switched to placebo regained two-thirds of the lost weight by week 68. This means maintenance dosing matters for sustaining results.

Annual maintenance cost on stable semaglutide dose: $2,400-$3,000 at either Hims or TrimRx. Some patients drop to lower maintenance doses (1.0-1.7 mg) after reaching goal weight, which can reduce monthly spend if pricing is dose-tiered.

For tirzepatide maintenance (TrimRx only), expect $3,000-$4,000 annually. SURMOUNT-4 will provide long-term tirzepatide maintenance data; preliminary results suggest similar dependence on continued dosing for sustained weight loss.

What About the SELECT and FLOW Evidence and Provider Value?

SELECT (Lincoff et al. 2023 NEJM) and FLOW (Perkovic et al. 2024 NEJM) extended the case for semaglutide beyond weight loss. SELECT showed 20% MACE reduction in CVD patients; FLOW showed 24% kidney disease progression reduction in diabetic CKD.

Patients with these conditions get more value per dollar from semaglutide because the medication is doing multiple jobs (weight, cardiovascular, kidney). The cost-per-pound math undersells the total clinical benefit.

Tirzepatide added SURMOUNT-OSA (FDA approval for obstructive sleep apnea, December 2024) to its label. Patients with OSA may find tirzepatide’s clinical value exceeds the pure weight loss metric, which favors providers that offer it.

Bottom line: Tirzepatide patients face higher costs and need a provider that offers it (TrimRx)

FAQ

Is Hims Cheaper Than TrimRx?

Entry pricing is similar; promotional first-month pricing at Hims can drop below $99 but reverts. Year-one cost is roughly $100-$150 cheaper at Hims; year-two costs converge.

Does Hims Offer Tirzepatide?

Generally no. Compounded semaglutide is the main GLP-1 option. Patients who want tirzepatide need a different provider.

Are the Medications Interchangeable?

Compounded semaglutide is the same active ingredient at both providers, sourced from licensed US pharmacies. Brand-name versus compounded distinction is regulatory, not pharmacological.

Can I Use HSA or FSA at Either?

Often yes when medication is prescribed for diagnosed obesity (BMI 30+) or type 2 diabetes. Submit receipt and prescription to your HSA/FSA administrator.

What About Hims’ Other Products?

Hair loss, ED medications, mental health, and skincare are sold separately. Bundling can simplify billing if you use multiple Hims products, but doesn’t change weight loss medication cost.

Are There Hidden Cancellation Fees?

Both providers don’t allow returns on shipped compounded medication. Cancellation timing matters: cancel before the next bill date to avoid being charged for unused product.

Does Either Accept GoodRx or Pharmacy Discount Cards?

No. Both are direct-to-consumer telehealth platforms with their own pricing. GoodRx applies to retail pharmacy prescriptions, which neither provider uses for compounded medication.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.